Long-Acting β-Agonists in Asthma Management

@article{Mysore2011LongActingI,
  title={Long-Acting β-Agonists in Asthma Management},
  author={Satya Mysore and Emeritus Professor Richard E. Ruffin},
  journal={Drugs},
  year={2011},
  volume={71},
  pages={2091-2097}
}
Large surveillance studies or phase IV clinical studies of long-acting β-agonists (LABA) compared with placebo in asthma patients using variable (from nil to regular) doses of inhaled corticosteroids (ICS) have raised the issue of mortality risk in patients with asthma taking regular LABA. There have been a number of meta-analyses and systematic reviews… CONTINUE READING